Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | GPR3 | P46089 | 2/20 | 0.48 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.46 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 3/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 3/20 | 0.45 |
| ▸ | F12 | P00748 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.39 |
| ▸ | GABRP | O00591 | 1/20 | 0.39 |
| ▸ | GABRD | O14764 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13183677 | 0.88 | ALKBH5 (0.50) | MAPTKDM4EGPR3ALKBH5FTO | |
| SCHEMBL17281061 | 0.85 | MAOB (0.43) | MAPTKDM4EGPR3TP53RXFP1 | |
| SCHEMBL12170772 | 0.84 | MAPT (0.49) | MAPTKDM4EGPR3TP53RXFP1 | |
| SCHEMBL17281048 | 0.84 | TP53 (0.43) | MAPTKDM4EGPR3ALKBH5FTO | |
| SCHEMBL20402131 | 0.81 | ALKBH5 (0.50) | MAPTKDM4EGPR3ALKBH5FTO | |
| SCHEMBL18416301 | 0.80 | KDM4E (0.51) | MAPTKDM4EGPR3ALKBH5FTO | |
| SCHEMBL16867206 | 0.80 | MAPT (0.51) | MAPTKDM4EGPR3ALKBH5FTO | |
| SCHEMBL16363009 | 0.80 | MAPT (0.51) | MAPTKDM4EGPR3ALKBH5FTO | |
| SCHEMBL20110473 | 0.79 | GPR3 (0.48) | MAPTKDM4EGPR3TP53RXFP1 | |
| SCHEMBL9754503 | 0.79 | PTGER4 (0.43) | MAPTKDM4ETP53RXFP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240032422-A1 | LIGHT-EMITTING MATERIAL, COMPOUND, LONG-PERSISTENT PHOSPHOR AND LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2024-01-25 | — | — | US | disclosed |
| US-11832516-B2 | Light-emitting material, compound, long-persistent phosphor and light-emitting element | KYULUX, INC. (JP) | 2023-11-28 | — | — | US | disclosed |
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20230210000-A1 | COMPOUND, LIGHT EMITTING MATERIAL, AND LIGHT EMITTING DEVICE | KYULUX, INC. (JP) | 2023-06-29 | — | — | US | disclosed |
| WO-1991014688-A1 | HETERO POLYCYCLIC BIOCIDAL COMPOUNDS AND THEIR USE IN MEDECINE | THE WELLCOME FOUNDATION LIMITED (GB) | 1991-10-03 | — | — | WO | disclosed |
| EP-0447703-A1 | Hetero polycyclic biocidal compounds, their synthesis and intermediates therefor,formulations containing them and their use in medicine | THE WELLCOME FOUNDATION LIMITED (GB) | 1991-09-25 | — | — | EP | disclosed |
| US-4999369-A | Antitumor agents | BURROUGHS WELLCOME CO. (US) | 1991-03-12 | — | — | US | disclosed |
| US-4910218-A | With a hydroxy containing secondary amine group | BURROUGHS WELLCOME CO. (US) | 1990-03-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240032422-A1 | LIGHT-EMITTING MATERIAL, COMPOUND, LONG-PERSISTENT PHOSPHOR AND LIGHT-EMITTING ELEMENT | NR2E3, CRY1, ESR1 | MAPT 1967/4885KDM4E 4118/4885GPR3 288/4885 |
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | CRY1, CCNE2, CRY2 | MAPT 1225/4885KDM4E 1997/4885GPR3 1535/4885 |
| US-20230210000-A1 | COMPOUND, LIGHT EMITTING MATERIAL, AND LIGHT EMITTING DEVICE | DRD1, DRD2, DRD3 | MAPT 2365/4885KDM4E 3283/4885GPR3 450/4885 |
| US-11832516-B2 | Light-emitting material, compound, long-persistent phosphor and light-emitting element | NR2E3, CRY1, ESR1 | MAPT 1967/4885KDM4E 4118/4885GPR3 288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.